Overview

Validation of a Test System for Development of Medications for Alcoholism

Status:
Completed
Trial end date:
2017-09-04
Target enrollment:
Participant gender:
Summary
Using theTEMA (test system for development of medications for alcoholism) it can be shown, that naltrexone administration reduces the willingness to perform work for alcohol infusion in a laboratory experiment.
Phase:
Phase 3
Details
Lead Sponsor:
Technische Universität Dresden
Treatments:
Naltrexone